<https://www.pharmaceutical-technology.com/analyst-comment/out-of-spec-cell-therapy-manufacturing-an-ethical-dilemma-for-cdmos-and-doctors/#primaryimage>
<http://schema.org/caption>
"Figure 1: Marketed cell, gene, and gene-modified cell therapies and their API outsourcing. Source: GlobalData, Pharma Intelligence Center Drugs by Manufacturer Database (Accessed November 29, 2023) ©GlobalData Note: The Drugs by Manufacturer database will only include biosimilar and innovator drugs approved in the US, UK, and/or EU, specifically through the EMA’s centralized authorization procedure."
<https://www.pharmaceutical-technology.com/analyst-comment/out-of-spec-cell-therapy-manufacturing-an-ethical-dilemma-for-cdmos-and-doctors/>